As detailed in the Price Disclosure Reductions (2021 April cycle) the Department of Health have advised the Take Home Naloxone (THN) Pilot has been updated to include new amounts payable for injectable forms of naloxone (Prenoxad, Naloxone Juno, Naloxone hydrochloride (DBL) and Junalox). These price changes will come into effect from 1 April 2021.
Any claims submitted with a date of supply on or after 1 April 2021 will be paid under these new amounts, which can be found here.
Any claims submitted with a date of supply on or before 31 March 2021 will be paid under the pricing arrangements that were in effect at the time of the supply (i.e. before the 1 April price changes).
As per existing guidelines, Authorised Alternative Suppliers do not receive payment for supply of naloxone products under the THN Pilot.